AMENDMENT NO. 1 TO THE SERIES B WARRANT TO PURCHASE COMMON STOCKSierra Oncology, Inc. • September 13th, 2021 • Pharmaceutical preparations • New York
Company FiledSeptember 13th, 2021 Industry JurisdictionThis Amendment No. 1 to the Series B Warrant to Purchase Common Stock dated September 8, 2021 is made effective as of September 8, 2021 (the “Amendment”), by and among Sierra Oncology, Inc., a Delaware corporation (the “Company”), and [ ] (the “Investor” and together with the Company, the “Parties”).